. Author manuscript; available in PMC: 2019 May 21.

Published in final edited form as: J Manag Care Spec Pharm. 2018 Feb;24(2):165–172. doi: 10.18553/jmcp.2018.24.2.165

TABLE 2.

Longitudinal Results for Patients Who Completed Adherence Intervention (n = 16)

	Baseline	6-Week Follow-up	3-Month Follow-up	6-Month Follow-up
CD4 count (cells/mm³)
Median	298	387^a	356^b	454^a
Interquartile range	93–427	176–492	171–565	181–654
HIV RNA (copies/mL)
Median	48,000	130^b	32^b	0^a
Interquartile range	16,750–139,000	59–1743	0–219	0–0

Note: All comparisons between baseline and specified follow-up time point.

P < 0.001.

P < 0.010.

HIV = human immunodeficiency virus.